YSB Inc.

Research YSB Inc. (B1S) on Bullrun: market cap EUR 241.89M, P/E 11.2, dividend yield 4.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerB1S
• ExchangeF
• CountryChina
• SectorHealthcare
• IndustryPharmaceutical Retailers
• CurrencyEUR
• Market capEUR 241.89M
• P/E11.2
• Dividend yield4.3%
• Financial periodFY2025
• RevenueEUR 20.97B
• Revenue growth17.1%
• Net incomeEUR 152.97M
• Free cash flowEUR 619.46M
• Gross margin11.0%

Valuation Snapshot

latest market cap is EUR 241.89M; P/E is 11.2; dividend yield is 4.3%.

About YSB Inc.

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that includes Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions;

Frequently asked questions

What is YSB Inc.'s market cap?

YSB Inc.'s market capitalization is EUR 241.89M.

What is YSB Inc.'s P/E ratio?

YSB Inc.'s price-to-earnings (P/E) ratio is 11.2.

Does YSB Inc. pay a dividend?

YSB Inc. has a dividend yield of 4.3%.

What does YSB Inc. do?

YSB Inc. operates a digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.